Neil Roy Curtis

Person

Buntingford, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Arylsulfonylnaphthalene derivatives as 5HT2A antagonists
- Patent number 7,592,456
- Issue date Sep 22, 2009
- Merck Sharp & Dohme Limited
- Mark Stuart Chambers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
5-HT7 receptor antagonists
- Patent number 7,276,607
- Issue date Oct 2, 2007
- Merck Sharp & Dohme Limited
- Neil Roy Curtis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
5-HT2A receptor ligands
- Patent number 7,094,777
- Issue date Aug 22, 2006
- Merk Sharp & Dohme Ltd.
- Mark Stuart Chambers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Azabicyclic ether derivatives and their use as therapeutic agents
- Patent number 6,727,249
- Issue date Apr 27, 2004
- Merck Sharp & Dohme Ltd.
- Neil Roy Curtis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of NK-1 receptor antagonists for treating major depressive diso...
- Patent number 6,613,765
- Issue date Sep 2, 2003
- Merck Sharp & Dohme Limited
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pentaaza-cyclopental[a]naphthalene derivatives as l...
- Patent number 6,613,766
- Issue date Sep 2, 2003
- Merck Sharp & Dohme Ltd.
- Neil Roy Curtis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrahydroindolone derivatives as gabaaalpha5 ligands for enhancing...
- Patent number 6,395,766
- Issue date May 28, 2002
- Merck Sharp & Dohme Limited
- Howard Barff Broughton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aryl amidines, compositions containing such compounds and methods o...
- Patent number 6,319,944
- Issue date Nov 20, 2001
- Merck & Co., Inc.
- Christopher F. Claiborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating cognitive disorders
- Patent number 6,271,230
- Issue date Aug 7, 2001
- Merck Sharp & Dohme Limited
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spiro-azacyclic derivatives and their use as therapeutic agents
- Patent number 6,172,077
- Issue date Jan 9, 2001
- Merck Sharp & Dohme Ltd.
- Neil Roy Curtis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of NK-1 receptor antagonists for treating major depressive diso...
- Patent number 6,114,315
- Issue date Sep 5, 2000
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptors antagonists for treating schizophrenic disorders
- Patent number 6,100,256
- Issue date Aug 8, 2000
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating amnestic disorders
- Patent number 6,096,729
- Issue date Aug 1, 2000
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating stress disorders
- Patent number 6,087,348
- Issue date Jul 11, 2000
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spiro-piperidine derivatives and their use as therapeutic agents
- Patent number 6,071,927
- Issue date Jun 6, 2000
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spiro-piperidine derivatives and their use as therapeutic agents
- Patent number 6,071,928
- Issue date Jun 6, 2000
- Merck Sharp & Dohme, Ltd.
- Neil Roy Curtis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating bipolar disorders
- Patent number 5,977,104
- Issue date Nov 2, 1999
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating bipolar disorders
- Patent number 5,952,315
- Issue date Sep 14, 1999
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating sexual dysfunctions
- Patent number 5,929,054
- Issue date Jul 27, 1999
- Merck Sharp
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating movement disorders
- Patent number 5,925,627
- Issue date Jul 20, 1999
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antogonists for treating substance use disorders
- Patent number 5,919,781
- Issue date Jul 6, 1999
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tetrahydropyridine derivatives as dopamine receptor subtype ligands
- Patent number 5,861,407
- Issue date Jan 19, 1999
- Merck Sharp & Dohme, Ltd.
- Neil Roy Curtis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tetrahydropyridine derivatives as dopamine receptor subtype ligands
- Patent number 5,849,765
- Issue date Dec 15, 1998
- Merck Sharp & Dohme, Ltd.
- Neil Roy Curtis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tetrahydropyridinylmethyl derivatives of pyrrolo�2,3-B!pyridine
- Patent number 5,830,901
- Issue date Nov 3, 1998
- Merch Sharp & Dohme Ltd
- Neil Roy Curtis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolo-pyridine derivatives
- Patent number 5,712,285
- Issue date Jan 27, 1998
- Merck, Sharp & Dohme, Ltd.
- Neil Roy Curtis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Furopyridine derivatives
- Patent number 5,700,802
- Issue date Dec 23, 1997
- Merck Sharp & Dohme, Ltd.
- Neil Roy Curtis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolo-pyridine derivatives
- Patent number 5,700,809
- Issue date Dec 23, 1997
- Merck Sharp & Dohme, Ltd.
- Paul David Leeson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methanesulfonate salts of antipsychotic benzofuran derivatives
- Patent number 5,681,836
- Issue date Oct 28, 1997
- Merck, Sharp & Dohme, Ltd.
- Neil Roy Curtis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolo-pyridine derivatives
- Patent number 5,622,950
- Issue date Apr 22, 1997
- Merck, Sharp & Dohme Ltd.
- Raymond Baker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolo-pyridine derivatives
- Patent number 5,576,319
- Issue date Nov 19, 1996
- Merck, Sharp & Dohme Ltd.
- Raymond Baker
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Arylsulfonyl Benzofused Heterocycles as 5-Ht2a Antagonists
- Publication number 20090012134
- Publication date Jan 8, 2009
- Neil Roy Curtis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Arylsulfonylnaphthalene Derivatives As 5Ht2a Antagonists
- Publication number 20070281952
- Publication date Dec 6, 2007
- Mark Stuart Chambers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel 5-HT2A receptor ligands
- Publication number 20050101586
- Publication date May 12, 2005
- Mark Stuart Chambers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
5-ht7 receptor antagonists
- Publication number 20050080077
- Publication date Apr 14, 2005
- Neil Roy Curtis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Amidine derivatives as selective antagonists of ndma receptors
- Publication number 20030119871
- Publication date Jun 26, 2003
- Neil Roy Curtis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Azabicyclic ether derivatives and their use as therapeutic agents
- Publication number 20020193402
- Publication date Dec 19, 2002
- Neil Roy Curtis
- C07 - ORGANIC CHEMISTRY

Neil Roy Curtis

Person

Patents Grantslast 30 patents

Arylsulfonylnaphthalene derivatives as 5HT2A antagonists

5-HT7 receptor antagonists

5-HT2A receptor ligands

Azabicyclic ether derivatives and their use as therapeutic agents

Use of NK-1 receptor antagonists for treating major depressive diso...

Pentaaza-cyclopental&#x0005B;a&#x0005D;naphthalene derivatives as l...

Tetrahydroindolone derivatives as gabaaalpha5 ligands for enhancing...

Aryl amidines, compositions containing such compounds and methods o...

Use of NK-1 receptor antagonists for treating cognitive disorders

Spiro-azacyclic derivatives and their use as therapeutic agents

Use of NK-1 receptor antagonists for treating major depressive diso...

Use of NK-1 receptors antagonists for treating schizophrenic disorders

Use of NK-1 receptor antagonists for treating amnestic disorders

Use of NK-1 receptor antagonists for treating stress disorders

Spiro-piperidine derivatives and their use as therapeutic agents

Spiro-piperidine derivatives and their use as therapeutic agents

Use of NK-1 receptor antagonists for treating bipolar disorders

Use of NK-1 receptor antagonists for treating bipolar disorders

Use of NK-1 receptor antagonists for treating sexual dysfunctions

Use of NK-1 receptor antagonists for treating movement disorders

Use of NK-1 receptor antogonists for treating substance use disorders

Tetrahydropyridine derivatives as dopamine receptor subtype ligands

Tetrahydropyridine derivatives as dopamine receptor subtype ligands

Tetrahydropyridinylmethyl derivatives of pyrrolo�2,3-B!pyridine

Pyrrolo-pyridine derivatives

Furopyridine derivatives

Pyrrolo-pyridine derivatives

Methanesulfonate salts of antipsychotic benzofuran derivatives

Pyrrolo-pyridine derivatives

Pyrrolo-pyridine derivatives

Patents Applicationslast 30 patents

Arylsulfonyl Benzofused Heterocycles as 5-Ht2a Antagonists

Arylsulfonylnaphthalene Derivatives As 5Ht2a Antagonists

Novel 5-HT2A receptor ligands

5-ht7 receptor antagonists

Amidine derivatives as selective antagonists of ndma receptors

Azabicyclic ether derivatives and their use as therapeutic agents

Pentaaza-cyclopental[a]naphthalene derivatives as l...